Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-73.58%Return on Assets
VS
Market
Sector
Industry
History
$ 0.56Close
$ 0.43 - $ 1.98 52-Week Range
Ticker Information
Ticker
SILOCompany Name
SILO PHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSILO PHARMA INC - Return on Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SILO - ROA Historical data
| Date | Total Assets | Net Income Common Stock | Return on Assets |
|---|---|---|---|
| 6/30/2025 | $ 6.65M | $ -4.9M | -73.58% |
| 3/31/2025 | $ 5.9M | $ -4.62M | -78.35% |
| 12/31/2024 | $ 7.41M | $ -4.39M | -59.27% |
| 9/30/2024 | $ 8.57M | $ -3.78M | -44.16% |
| 6/30/2024 | $ 8.04M | $ -3.51M | -43.73% |
| 3/31/2024 | $ 6.94M | $ -3.6M | -51.8% |
| 12/31/2023 | $ 7.75M | $ -3.7M | -47.77% |
| 9/30/2023 | $ 8.99M | $ -4.24M | -47.21% |
| 6/30/2023 | $ 10.25M | $ -4.57M | -44.56% |
| 3/31/2023 | $ 11.02M | $ -4.21M | -38.2% |
Key Performance Insights, Last 5 Years
- SILO PHARMA INC's latest trailing twelve months (TTM) ROA stands at -122.44%.
- Over the past 5 years, SILO PHARMA INC's average ROA has been -48.52%.
- The median ROA for SILO PHARMA INC during this period was -45.88%
- SILO PHARMA INC reached its highest ROA over the past 5 years at 44.6%.
- The lowest ROA recorded by SILO PHARMA INC in the same timeframe -217.75%
SILO PHARMA INC's ROA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROA Benchmarks
Similar metrics to ROA:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Equity - [Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
Definition of Return on Assets
[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.Net Inc. Cmn. / Assets
(=) ROA ROA for SILO PHARMA INC is calculated as follows: Net Inc. Cmn. [ $ -2.7M ] / Assets [ $ 2.2M ]
(=) ROA [ -122.44% ] SILO - Return on Assets, Last 5 years
-217.75%
Minimum
Dec 31, 2020
44.6%
Maximum
Jun 30, 2022
-48.52%
Average
-45.88%
Median
ROA Benchmark AnalysisMarket
The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.12% with a standard deviation of 10.61%.
The following table provides additional summary stats:
ROA in the Market:
| filtered constituents | 3.44K |
|---|---|
| min | -33.4% |
| max | 33.98% |
| average | 0.12% |
| median | 1.53% |
| std | 10.61% |